Indicated for the treatment of patients with advanced colorectal cancer:
In combination with 5-fluorouracil and folinic acid, in patients without prior chemotherapy for advanced disease.
As monotherapy for patients who have failed an established treatment regimen containing 5-fluorouracil.
IRINOTECAN
Concentrate for solution for injection for intravenous use
Each 5 mL of injectable solution contains Irinotecan hydrochloride trihydrate 100 mg. Box with 1 vial with 5 mL for injectable solution
Each 5 mL vial contains:
Irinotecan hydrochloride trihydrate 100 mg
PF-46320
F022808062017
HN-M-0618-0241
´011682803-20
M-AR-20-00374
201503
